120 related articles for article (PubMed ID: 2790683)
1. Relationship of histopathologic features to survival and relapse in nodular sclerosing Hodgkin's disease. A study of 1659 patients.
MacLennan KA; Bennett MH; Tu A; Hudson BV; Easterling MJ; Hudson GV; Jelliffe AM
Cancer; 1989 Oct; 64(8):1686-93. PubMed ID: 2790683
[TBL] [Abstract][Full Text] [Related]
2. Histopathologic grading of nodular sclerosis Hodgkin's disease. Lack of prognostic significance in 254 surgically staged patients.
Hess JL; Bodis S; Pinkus G; Silver B; Mauch P
Cancer; 1994 Jul; 74(2):708-14. PubMed ID: 8033052
[TBL] [Abstract][Full Text] [Related]
3. Tissue eosinophilia correlates strongly with poor prognosis in nodular sclerosing Hodgkin's disease, allowing for known prognostic factors.
von Wasielewski R; Seth S; Franklin J; Fischer R; Hübner K; Hansmann ML; Diehl V; Georgii A
Blood; 2000 Feb; 95(4):1207-13. PubMed ID: 10666192
[TBL] [Abstract][Full Text] [Related]
4. The prognostic significance of cellular subtypes in nodular sclerosing Hodgkin's disease: an analysis of 271 non-laparotomised cases (BNLI report no. 22).
Bennett MH; MacLennan KA; Easterling MJ; Vaughan Hudson B; Jelliffe AM; Vaughan Hudson G
Clin Radiol; 1983 Sep; 34(5):497-501. PubMed ID: 6617080
[TBL] [Abstract][Full Text] [Related]
5. Does histology influence outcome in childhood Hodgkin's disease? Results from the United Kingdom Children's Cancer Study Group.
Shankar AG; Ashley S; Radford M; Barrett A; Wright D; Pinkerton CR
J Clin Oncol; 1997 Jul; 15(7):2622-30. PubMed ID: 9215833
[TBL] [Abstract][Full Text] [Related]
6. Clinical presentation and outcome in lymphocyte-predominant Hodgkin's disease.
Bodis S; Kraus MD; Pinkus G; Silver B; Kadin ME; Canellos GP; Shulman LN; Tarbell NJ; Mauch PM
J Clin Oncol; 1997 Sep; 15(9):3060-6. PubMed ID: 9294468
[TBL] [Abstract][Full Text] [Related]
7. [Prognostic relevance of histopathologic subtyping of nodular-sclerotic types of Hodgkin's disease].
Adamkov M; Plank L
Bratisl Lek Listy; 1990 Jun; 91(6):433-6. PubMed ID: 2393825
[TBL] [Abstract][Full Text] [Related]
8. Syncytial variant of nodular sclerosing Hodgkin's disease. A new clinicopathologic entity.
Ben-Yehuda-Salz D; Ben-Yehuda A; Polliack A; Ron N; Okon E
Cancer; 1990 Mar; 65(5):1167-72. PubMed ID: 2406009
[TBL] [Abstract][Full Text] [Related]
9. A comparative study of the nodular and diffuse variants of lymphocyte-predominant Hodgkin's disease.
Borg-Grech A; Radford JA; Crowther D; Swindell R; Harris M
J Clin Oncol; 1989 Sep; 7(9):1303-9. PubMed ID: 2769329
[TBL] [Abstract][Full Text] [Related]
10. Prognostic factors in Hodgkin's disease. I. Analysis of histopathology, stage distribution and results of therapy.
Björkholm M; Holm G; Mellstedt H; Johansson B; Askergren J; Söderberg G
Scand J Haematol; 1977 Nov; 19(5):487-95. PubMed ID: 594663
[TBL] [Abstract][Full Text] [Related]
11. Disappearance of prognostic significance of histopathological grading of nodular sclerosing Hodgkin's disease for unselected patients, 1972-92.
van Spronsen DJ; Vrints LW; Hofstra G; Crommelin MA; Coebergh JW; Breed WP
Br J Haematol; 1997 Feb; 96(2):322-7. PubMed ID: 9029020
[TBL] [Abstract][Full Text] [Related]
12. [Lymphoid depletion type 4 Hodgkin disease. Anatomoclinical review of 35 cases].
Eghbali H; Pétorin C; de Mascarel I; Trojani M; Hoerni-Simon G; Soubeyran P; Hoerni B
Bull Cancer; 1994 Oct; 81(10):866-70. PubMed ID: 7734769
[TBL] [Abstract][Full Text] [Related]
13. Significance of cell proliferation index in assessing histological prognostic categories in Hodgkin's disease. An immunohistochemical study with Ki67 and MIB-1 monoclonal antibodies.
Abele MC; Valente G; Kerim S; Navone R; Onesti P; Chiusa L; Resegotti L; Palestro G
Haematologica; 1997; 82(3):281-5. PubMed ID: 9234572
[TBL] [Abstract][Full Text] [Related]
14. Review of British National Lymphoma Investigation studies of Hodgkin's disease and development of prognostic index.
Haybittle JL; Hayhoe FG; Easterling MJ; Jelliffe AM; Bennett MH; Vaughan Hudson G; Vaughan Hudson B; MacLennan KA
Lancet; 1985 Apr; 1(8435):967-72. PubMed ID: 2859421
[TBL] [Abstract][Full Text] [Related]
15. The pathologic and clinical heterogeneity of lymphocyte-depleted Hodgkin's disease.
Kant JA; Hubbard SM; Longo DL; Simon RM; DeVita VT; Jaffe ES
J Clin Oncol; 1986 Mar; 4(3):284-94. PubMed ID: 3754003
[TBL] [Abstract][Full Text] [Related]
16. Grades of nodular sclerosis (NSI-NSII) in Hodgkin's disease. Are they of independent prognostic value?
Wijlhuizen TJ; Vrints LW; Jairam R; Breed WP; Wijnen JT; Bosch LJ; Crommelin MA; van Dam FE; de Koning J; Verhagen-Teulings M
Cancer; 1989 Mar; 63(6):1150-3. PubMed ID: 2917317
[TBL] [Abstract][Full Text] [Related]
17. Hodgkin's disease and non-Hodgkin's lymphoma containing Reed-Sternberg-like giant cells in Taiwan. A clinicopathologic analysis of 50 cases.
Hong RL; Su IJ; Chen YC; Hsieh HC; Wang CH; Liu CH; Shen MC
Cancer; 1992 Mar; 69(5):1254-8. PubMed ID: 1739924
[TBL] [Abstract][Full Text] [Related]
18. Improved survival in patients with limited stage IIIA Hodgkin's disease treated with combined radiation therapy and chemotherapy.
Marcus KC; Kalish LA; Coleman CN; Shulman LN; Rosenthal DS; Canellos GP; Mauch PM
J Clin Oncol; 1994 Dec; 12(12):2567-72. PubMed ID: 7989930
[TBL] [Abstract][Full Text] [Related]
19. Follicular dendritic cells have prognostic relevance in Hodgkin's disease.
Alavaikko MJ; Blanco G; Aine R; Lehtinen T; Fellbaum C; Taskinen PJ; Sarpola A; Hansmann ML
Am J Clin Pathol; 1994 Jun; 101(6):761-7. PubMed ID: 8209866
[TBL] [Abstract][Full Text] [Related]
20. Nodular and diffuse types of lymphocyte predominance Hodgkin's disease.
Regula DP; Hoppe RT; Weiss LM
N Engl J Med; 1988 Jan; 318(4):214-9. PubMed ID: 3336412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
